Description
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of the full 44-amino acid sequence of endogenous GHRH with a trans-3-hexenoic acid group attached. This modification enhances its stability and half-life compared to native GHRH, making it a valuable compound in growth hormone and metabolic research.
In laboratory models, Tesamorelin has been studied for its ability to stimulate pituitary GH release in a physiologically regulated manner. Researchers have explored its potential effects on visceral adipose tissue reduction, lean body mass support, and overall metabolic function. Its influence on IGF-1 levels and lipid metabolism has also made it a focus in endocrine and body composition research.
Key Research Features:
– GHRH Analogue Activity: Studied for its ability to stimulate physiological GH release from the pituitary gland
– Visceral Fat Research: Investigated for its potential effects on visceral adipose tissue in laboratory models
– Metabolic Regulation: Explored for its influence on lipid metabolism and energy balance
– Body Composition Studies: Associated with lean mass support and fat reduction research
– Research-Grade Quality: Intended strictly for laboratory and scientific research purposes only




Reviews
There are no reviews yet.